Dr. Pamela A. (Martoglio) Smith has joined Improved Pharma as COO. Dr. Smith was most recently Vice President of Analytical Services for AMRI, where she was responsible for 300 employees at four global sites. One of those sites included SSCI, the cGMP contract research organization founded by Dr. Steve Byrn and Sally Byrn. She has a long history with SSCI, having joined it in 1999 as a Research Scientist specializing in vibrational spectroscopy and solid state method development. When SSCI was acquired by Aptuit in 2006, she assumed P&L responsibility for the analytical division of SSCI. In 2009, Dr. Smith was asked to become a Lean Six Sigma black belt and she generated over $2M in benefits during her tenure in this role. Eventually, she assumed the role of General Manager for SSCI, where she led the site to record performances for multiple years, culminating in the successful sale of SSCI to AMRI for $36M. Upon joining Improved Pharma, Dr. Smith states “I’m very pleased to have the opportunity to work once again with the Byrns. Steve is a highly respected leader in his field, and I am confident that Improved Pharma will be another successful endeavor. I’m looking forward to growing the company as we expand upon our offerings with cutting-edge developments in the pharmaceutical development space, and I look forward to working with our clients to help them succeed in their projects.